Moving Forward: The Future of GLP-1 Therapies
The medical landscape for treating obesity and metabolic dysfunction is undergoing a seismic shift, transitioning from a reactive model centered…
chronic conditions
Amara Maple Endocrine Society Announces Five Recipients of the 2026 Early Investigator Awards Recognizing Excellence in Hormonal Research
The Endocrine Society has officially named five distinguished scientists as the winners of the 2026 Early Investigator Awards, a prestigious…
Endocrine Society Endorses Bipartisan INSULIN Act to Cap Out-of-Pocket Costs at Thirty-Five Dollars and Expand Market Competition
The Endocrine Society, the world’s oldest and largest organization of scientists and clinicians dedicated to hormone research and the clinical…
The Evolution of GLP-1 Receptor Agonists and Their Expanding Role in Cardiovascular Health for Type 2 Diabetes Patients
The clinical landscape for metabolic health underwent a significant transformation in late 2025 as new data emerged regarding the cardiovascular…
New Clinical Standard Aims to Close the Diagnosis Gap for Obesity as a Chronic Disease
The integration of obesity recognition into routine clinical practice has taken a significant step forward with the introduction of a…
Early-life Exposure to Per- and Polyfluoroalkyl Substances and Adolescent Bone Mineral Density: Assessing Periods of Susceptibility
The pervasive presence of synthetic "forever chemicals" in the environment has long been a subject of intense scientific scrutiny, but…
Legacy of Excellence: The Life and Work of Professor Martin O. Savage, Pioneer of Pediatric Endocrinology
The global medical community is mourning the loss of Professor Martin O. Savage, Emeritus Professor of Pediatric Endocrinology at the…
Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding
The United States Congress has officially passed a comprehensive funding bill for the Department of Health and Human Services (HHS)…
Beyond the Scale: How GLP-1 Receptor Agonists are Redefining Metabolic Health Across Diverse Patient Populations
The clinical landscape of metabolic medicine is undergoing a seismic shift as glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed to…
High Body Mass Index and Hypertension Identified as Direct Causal Factors in the Development of Vascular-Related Dementia
A landmark study published in The Journal of Clinical Endocrinology & Metabolism (JCEM) has provided definitive evidence linking obesity and…
